Immunologic changes to autologous transfusion after operational trauma in malignant tumor patients:Neopterin and Interleukin-2

被引:0
|
作者
严敏
陈钢
房玲玲
柳子明
张秀来
机构
[1] China
[2] Zhejiang University
[3] Second Affiliated Hospital
[4] School of Medicine
[5] Department of Anesthesiology
[6] Hangzhou310009
关键词
Autologous transfusion; Allogeneic transfusion; Serum Neopterin; INF-gamma; Immunoloic change;
D O I
暂无
中图分类号
R730.5 [肿瘤治疗学];
学科分类号
100214 ;
摘要
Objective:To estimate the impact of autologous transfusion on the status of perioperative immune activation inmalignant tumor patients.The Serum Neopterin and Interleukin-2(IL-2)were measured.Methods:Sixty patients undergoingelective radical resection for malignant stomach tumor were enrolled in the prospective study and assigned to the following groups:(Ⅰ)Group A received autologous transfusion;(2)Group H received allogeneic transfusion.The perioperative course(Beforeinduction of anesthesia,after operation and 5 d after operation)of Neopterin and IL-2 was compared.Results:In group A,SerumNeopterin was significantly lower than baseline alter operation and IL-2 had no significant changes.In group H,both SerumNeopterin and IL-2 were significantly lower than baseline alter operation and 5 d after operation.Compared with group A,SerumNeopterin was significantly lower than baseline alter operation and 5 d after operation and IL-2 was significantly lower thanbaseline 5 d alter operation.Conchision:Autologous
引用
收藏
页码:51 / 54
页数:4
相关论文
共 50 条
  • [1] Immunologic changes to autologous transfusion after operational trauma in malignant tumor patients: Neopterin and Interleukin-2
    Yan M.
    Chen G.
    Fang L.-L.
    Liu Z.-M.
    Zhang X.-L.
    Journal of Zhejiang University-SCIENCE B, 2005, 6 (1): : 49 - 52
  • [2] REACTION OF HUMAN TUMOR EXPLANTS TO INTERLEUKIN-2 AND EXPRESSION OF INTERLEUKIN-2 RECEPTORS ON AUTOLOGOUS TUMOR-CELLS
    BEREZHNAYA, NM
    OSIPOVA, EV
    KOVALCHUK, EV
    TOLSTOPYATOV, BA
    KONOVALENKO, VF
    PROTSYK, VS
    TREMBACH, AM
    GORDIENKO, SM
    EKSPERIMENTALNAYA ONKOLOGIYA, 1994, 16 (2-3): : 181 - 186
  • [3] SOLUBLE INTERLEUKIN-2 RECEPTOR AND URINARY NEOPTERIN CONCENTRATIONS IN MALIGNANT-LYMPHOMA
    PICCININI, L
    ZIRONI, S
    CENCI, AM
    CAMPIOLI, D
    FEDERICO, M
    BARBIERI, F
    EUROPEAN JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1993, 31 (09): : 567 - 574
  • [4] TUMOR IMAGING BY IN-111 LABELED LYMPHOCYTES AFTER SENSITIZATION TO AUTOLOGOUS TUMOR AND EXPANSION WITH INTERLEUKIN-2
    MUKHERJI, B
    SPITZNAGLE, LA
    SPENCER, RP
    ARNBJARNARSON, O
    ERGIN, MT
    JOURNAL OF NUCLEAR MEDICINE, 1986, 27 (06) : 970 - 971
  • [5] TREATMENT OF PATIENTS WITH METASTATIC MELANOMA WITH AUTOLOGOUS TUMOR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2
    ROSENBERG, SA
    YANNELLI, JR
    YANG, JC
    TOPALIAN, SL
    SCHWARTZENTRUBER, DJ
    WEBER, JS
    PARKINSON, DR
    SEIPP, CA
    EINHORN, JN
    WHITE, DE
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (15) : 1159 - 1166
  • [6] Changes and clinical significances of serum soluble interleukin-2 receptor in patients with mechanical trauma
    张喜平
    陈启龙
    程琪辉
    冯义国
    刘效恭
    Journal of Medical Colleges of PLA, 2002, (01) : 56 - 59
  • [8] GROWTH AND AUTOLOGOUS TUMOR LYSIS BY TUMOR-INFILTRATING LYMPHOCYTES FROM METASTATIC MELANOMA EXPANDED IN INTERLEUKIN-2 OR INTERLEUKIN-2 PLUS INTERLEUKIN-4
    LINDGREN, CG
    THOMPSON, JA
    HIGUCHI, CM
    FEFER, A
    JOURNAL OF IMMUNOTHERAPY, 1993, 14 (04): : 322 - 328
  • [9] Neopterin, soluble receptors for interleukin-2 and tumor necrosis factor in viral cirrhosis and alcoholic cirrhosis
    Gonzalez-Calvin, J
    Tilz, GP
    Gallego-Rojo, F
    Torres-Almendros, M
    Widner, B
    Diez-Ruiz, A
    Rico-Irles, J
    Fuchs, D
    PTERIDINES, 2000, 11 (02) : 43 - 47
  • [10] Interleukin-2 before and/or after autologous bone marrow transplantation for pediatric acute leukemia patients
    Messina, C
    Zambello, R
    Rossetti, F
    Gazzola, MV
    Varotto, S
    Destro, R
    Basso, G
    Semenzato, G
    Zanesco, L
    BONE MARROW TRANSPLANTATION, 1996, 17 (05) : 729 - 735